neominophagen c has been researched along with glycine in 12 studies
*Glycine: A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. [MeSH]
*Glycine: A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. [MeSH]
| Studies (neominophagen c) | Trials (neominophagen c) | Recent Studies (post-2010) (neominophagen c) | Studies (glycine) | Trials (glycine) | Recent Studies (post-2010) (glycine) |
|---|---|---|---|---|---|
| 13 | 2 | 0 | 35,163 | 756 | 8,415 |
| Protein | Taxonomy | neominophagen c (IC50) | glycine (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.4852 | |
| Sodium- and chloride-dependent glycine transporter 1 | Homo sapiens (human) | 106 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.3253 | |
| Sodium- and chloride-dependent glycine transporter 2 | Homo sapiens (human) | 128 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, M; Koike, M; Miyashiro, E; Sumiyama, K | 1 |
| Wang, JT | 1 |
| Iwabuchi, S; Osada, T; Takatori, M; Yoshida, H | 1 |
| Acharya, SK; Dasarathy, S; Joshi, YK; Tandon, A; Tandon, BN | 1 |
| Balderson, GA; Lynch, SV; Matsunami, H; Strong, RW | 1 |
| KIMURA, Y; MAEDA, S; OKAMURA, S | 1 |
| Ishiguro, M; Mikasa, S; Otani, M | 1 |
| Kumada, H; Tsubota, A | 1 |
| Imazeki, F | 1 |
| Yamada, G | 1 |
| Mitsuyoshi, H; Nakashima, T; Okanoue, T; Sumida, Y | 1 |
| Bi, MR; Chen, LY; Ma, YJ; Wang, Y; Yang, BS | 1 |
5 review(s) available for neominophagen c and glycine
| Article | Year |
|---|---|
[Long-term interferon (IFN), neominophagen C (SNMC) combination therapy of active liver cirrhosis type C].
Topics: Biomarkers; Cysteine; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Glycine; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Middle Aged; Oleanolic Acid; RNA, Viral | 1994 |
[Therapeutic strategies for hepatitis C].
Topics: Antiviral Agents; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Interferons; Oleanolic Acid; Pharmacogenetics; Phlebotomy; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Ursodeoxycholic Acid | 2004 |
[Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Iron, Dietary; Liver Neoplasms; Oleanolic Acid; Phlebotomy; Prognosis; Ribavirin; Time Factors | 2004 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
[Treatment of nonalcoholic steatohepatitis (NASH)].
Topics: Cysteine; Diet; Drug Combinations; Fatty Liver; Glycine; Hepatitis; Humans; Insulin Resistance; Liver Transplantation; Obesity; Oleanolic Acid; Oxidative Stress; Ursodeoxycholic Acid; Vitamin E | 2004 |
2 trial(s) available for neominophagen c and glycine
| Article | Year |
|---|---|
[A double-blind study of strong neominophagen-C in treating chronic hepatitis].
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Cysteine; Double-Blind Method; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhiza; Glycyrrhizic Acid; Hepatitis; Humans; Male; Oleanolic Acid; Plants, Medicinal | 1984 |
A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure.
Topics: Adolescent; Adult; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhiza; Humans; Interferon Inducers; Liver Failure; Male; Middle Aged; Oleanolic Acid; Plants, Medicinal | 1993 |
5 other study(ies) available for neominophagen c and glycine
| Article | Year |
|---|---|
Combination therapy with transfer factor and high dose stronger neo-minophagen C in chronic hepatitis B in children (HBe Ag positive).
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Combined Modality Therapy; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B e Antigens; Hepatitis, Chronic; Humans; Infant; Injections, Intravenous; Male; Oleanolic Acid; Solutions; Time Factors; Transfer Factor | 1991 |
Use of glycyrrhizin for recurrence of hepatitis B after liver transplantation.
Topics: Chronic Disease; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhiza; Hepatitis B; Humans; Liver Transplantation; Middle Aged; Oleanolic Acid; Plants, Medicinal; Recurrence | 1993 |
[The effect of strong neominophagen C on the formation of experimental pulmonary tuberculous cavity].
Topics: Cysteine; Drug Combinations; Glycine; Oleanolic Acid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[A case of acute poisoning caused by the inhalation of a nonselective herbicide REBIN GT SC (butafenacil and glyphosate isopropylamine)].
Topics: Acute Disease; Aged; Cysteine; Drug Combinations; Fluid Therapy; Glutathione; Glycine; Glyphosate; Herbicides; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Infusions, Intravenous; Inhalation Exposure; Male; Oleanolic Acid; Pyrimidines; Treatment Outcome | 2004 |
[Molecular mechanisms of the protection of SNMC in HepG2 cell apoptosis].
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cysteine; Drug Combinations; Glycine; Glycyrrhiza; Humans; Liver Neoplasms; Oleanolic Acid | 2005 |